A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)

NCT00308347 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1513

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes
Nephropathy

Interventions

DRUG: MK0954, losartan / Duration of Treatment: mean 3.4 years
DRUG: Placebo / Duration of Treatment: mean 3.4 years

Sponsor

Organon and Co